Anas, Ayesha C.
HRN: 25-74-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2024
MUPIROCIN 2%, 15G (TUBE)
09/29/2024
10/05/2024
TOPICAL
Thin Layer
TID
Staphylococcal Skin Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes